Cite
Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis.
MLA
Weinstein, Ilon C., et al. “Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-Analysis.” European Urology Oncology, vol. 6, no. 4, Aug. 2023, pp. 355–65. EBSCOhost, https://doi.org/10.1016/j.euo.2023.04.004.
APA
Weinstein, I. C., Wu, X., Hill, A., Brennan, D., Omil-Lima, D., Basourakos, S., Brant, A., Lewicki, P., Al Hussein Al Awamlh, B., Spratt, D., Bittencourt, L. K., Scherr, D., Zaorsky, N. G., Nagar, H., Hu, J., Barbieri, C., Ponsky, L., Vickers, A. J., & Shoag, J. E. (2023). Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis. European Urology Oncology, 6(4), 355–365. https://doi.org/10.1016/j.euo.2023.04.004
Chicago
Weinstein, Ilon C, Xian Wu, Alexander Hill, Donald Brennan, Danly Omil-Lima, Spyridon Basourakos, Aaron Brant, et al. 2023. “Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-Analysis.” European Urology Oncology 6 (4): 355–65. doi:10.1016/j.euo.2023.04.004.